Implications for Clinical Trial Design Following Introduction of New Endpoints That are Accepted for Registration

Time: 1:30 pm
day: Day 1 Track 3 PM


  • Exploring how the introduction of new endpoints will affect patient selection and trial execution
  • Outlining what introducing new endpoints means for broad CKD vs specific indications and factors to consider, such as clinical relevance, feasibility and trial logistics
  • Ensuring clear explanations are laid out for the clinical implementation of novel endpoints in CKD trials